The hemodynamics of human septic shock relate to circulating innate immunity factors

Immunological Investigations

Volumn 39, Issue 8, 2010, Pages 849-862

  Hartemink, Koen J ^a,b   Groeneveld, A B Johan ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Complement; Cytokines; Myocardial depression; Septic shock; Vasodilation

Indexed keywords

COMPLEMENT COMPONENT C3A; DOBUTAMINE; DOPAMINE; INTERLEUKIN 6; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE AGENT;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BLOOD CULTURE; CIRCULATION; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HUMAN; HYPOTENSION; INNATE IMMUNITY; INTENSIVE CARE UNIT; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY CATHETER; SEPTIC SHOCK; SYSTEMIC VASCULAR RESISTANCE; TACHYCARDIA; VASODILATATION;

ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHIES; CATHETERIZATION, SWAN-GANZ; COMPLEMENT ACTIVATION; COMPLEMENT C3A; FEMALE; HEMODYNAMICS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; INTERLEUKIN-6; MALE; MIDDLE AGED; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA; VASODILATION; VENTRICULAR FUNCTION; YOUNG ADULT;

EID: 77958160706     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2010.502949     Document Type: Article

References (32)

1. Cain, B. S., Medrum, D. R., Dinarello, C. A., et al. (1999). Tumor necrosis factor-a and interleukin-1ß synergistically depress human myocardial function. Crit. Care Med. 27:1309-18.
2. Damas, P., Canivet, J. L., De Grootte, D., et al. (1997). Sepsis and serum cytokine concentrations. Crit. Care Med. 25:405-412.
3. Del Balzo, U., Polley, M. J., Levi, R. (1988). Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects. J. Pharmacol. Exp. Ther. 246:911-916.
4. Flierl, M. A., Rittirsch, D., Huber-Lang, M. S., Sarma, J. V., Ward, P. A. (2008). Molecular events in the cardiomyopathy of sepsis. Mol. Med. 14:327-336.
5. Flierl, M. A., Rittirsch, D., Nadeau, B. A., et al. (2008). Functions of the complement components C3 and C5 during sepsis. FASEB J. 22:3483-90.
6. Groeneveld, A. B. J., Bronsveld, W., Thijs, L. G. (1986). Hemodynamic determinants of mortality in human septic shock. Surgery 99:140-152.
7. Groeneveld, A. B. J., Hartemink, K. J., de Groot, M. C. M., Visser, J., Thijs, L. G. (1999). Circulating endothelin and nitrate-nitrite relate to hemodynamic and metabolic variables in human septic shock. Shock 11:160-166.
8. Groeneveld, A. B. J., Tacx, A. N., Bossink, A. W. J., van Mierlo, G. J., Hack, C. E. (2003). Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection. Clin. Immunol. 1:106-115.
9. Guo, R.-F., Ward, P. A. (2005). Role of C5a in inflammatory responses. Annu. Rev. Immunol. 23:821-852.
10. Hack, C. E., Nuijens, J. H., Felt-Bersma, R. J., et al. (1989). Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am. J. Med. 86:20-26.
11. Hack, C. E., de Groot, E. R., Felt-Bersma, R. J. F., et al. (1989). Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704-1710.
12. Hartemink, K. J., Groeneveld, A. B., de Groot, M. C., Strack van Schijndel, R. J., van Kamp, G., Thijs, L. G. (2001). Alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in plasma as markers of myocardial depression in human septic shock. Crit. Care Med. 29:80-87.
13. Helle, M., Boeije, L., de Groot, E., de Vos, A., Aarden, L. A. (1991). Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera. J. Immunol. Meth. 138:47-56.
14. Hoesel, L. M., Niederbichler, A. D., Ward, P. A. (2007). Complement-related molecular events in sepsis leading to heart failure. Mol. Immunol. 44:95-102.
15. Huey, R., Bloor, C. M., Hugli, T. E. (1984). Effects of human anaphylatoxins on guinea pig atria. Immunopharmacology 8:147-154. (Pubitemid 16162324)
16. Iversen, P. O., Nicolaysen, A., Kvernebo, K., Benestad, H. B., Nicolaysen, G. (1999). Human cytokines modulate arterial vascular tone via endothelial receptors. Eur. J. Physiol. 439:93-100.
17. Janssen, S. P. M., Gayan-Ramirez, G., Van den Bergh, A., et al. (2005). Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111:996-1005.
18. Joulin, O., Petillot, P., Labalette M., Lancel S., Neviere R. (2007). Cytokine profile of human septic shock serum inducing cardiomyocyte contractile dysfunction. Physiol. Res. 56:291-297.
19. Kofler, S., Nickerl, T., Weis, M. (2005). Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin. Sci. 108:205-213.
20. Kumar, A., Kumar, A., Paladugu, B., Mensing, J., Parrillo, J. E. (2007). Transforming growth factor-ß1 blocks in vitro cardiac myocyte depression induced by tumor necrosis factor-a, interleukin-1ß, and human septic shock serum. Crit. Care Med. 35:358-364.
21. Metrangolo, L., Fiorillo, M., Friedman, G., et al. (1995). Early hemodynamic course of septic shock. Crit. Care Med. 23:1971-1975.
22. Ognibene, F. P., Parker, M. M., Burch-Whitman, C., et al. (1988). Neutrophil aggregating activity and septic shock in humans: neutrophil aggregation by a C5a-like material occurs more frequently than complement component depletion and correlates with depression of systemic vascular resistance. J. Crit. Care 3:103-111.
23. Ohkawa, F., Ikeda, U., Kanbe, T., Kawasaki, K., Shimada, K. (1995). Effects of inflammatory cytokines on vascular tone. Cardiovasc. Res. 30:711-715.
24. Patel, R. T., Deen, K. I., Youngs, D., Warwick, J., Keighley, M. R. B. (1994). Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br. J. Surg. 81:1306-1309.
25. Pathan, N., Hemingway, C. A., Alizadeh, A. A., et al. (2004). Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. Lancet 363:203-209.
26. Pinsky, M. R., Vincent, J. L., Deviere, J., Alegre, M., Kahn, R. J., Dupont, E. (1993). Serum cytokine levels in human septic shock. Relation to multiple organ failure and mortality. Chest 103:565-575.
27. Riché, F. C., Cholley, B., Panis, Y. H., et al. (2000). Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis. Crit. Care Med. 28:433-437.
28. Selberg, O., Hecker, H., Martin, M., Klos, A., Bautsch, W., Köhl, J. (2000). Discrimination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit. Care Med. 28:2793-2798.
29. Vila, E., Salaices, M. (2005). Cytokines and vascular reactivity in resistance arteries. Am. J. Physiol. Heart Circ. Physiol. 288: H1016-1021.
30. Vincent, J. L., Bakker, J., Marécaux, G., Schandene, L., Kahn, R. J., Dupont, E. (1992). Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study. Chest 101:810-815.
31. Wolbink, G.-J., Bossink, A. W. J., Groeneveld, A. B. J., de Groot, M. C. M., Thijs, L. G., Hack, C. E. (1998). Complement activation in patients with sepsis is in part mediated by C-reactive protein. J. Infect. Dis. 177:81-87.
32. Wouters, D., Wagenaar-Bos, I., van Ham, M., Zeerleder, S. (2008). C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor. Expert Opin. Biol. Ther. 8:1225-1240.